Rituximab: a new therapeutic alternative in rheumatoid arthritis.
about
Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: data from the autoimmunity and rituximab registry.Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial.Novel applications of Rituximab in dermatological disordersNon-infectious pulmonary toxicity of rituximab: a systematic review.In vitro eradication of citrullinated protein specific B-lymphocytes of rheumatoid arthritis patients by targeted bifunctional nanoparticles.The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials.Rituximab: a review of dermatological applications.Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximabRituximab-induced interstitial lung disease: five case reports.CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis.Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.
P2860
Q30645118-14BAAC68-3088-44BA-A15F-F65A69457E0FQ30807010-6077EA20-F676-4369-9235-4665109C443FQ34087599-9FC9E223-EF2B-4D57-8CA3-CBD9610DD8EBQ34096300-6B66065D-42CF-4FF7-BEF1-A6DD864061D2Q36477500-4ED54E4D-D6B3-411D-A5EE-06CC5C244CEFQ37754083-77FB381B-1FB0-4D08-B06F-B66E0906E6CAQ37781697-F3D53C7C-4545-4332-9B05-2B61557140A8Q42372516-70EFD297-AFE5-4237-9492-DA8B998A96C8Q43192625-0EE8B504-BF98-4D91-B466-FB1EE36EAAE2Q45925746-9F4DDF58-9164-486E-9A59-B835CAD4521EQ50980453-A410D43E-CB4A-46D5-8BAE-C7DD380A9C6B
P2860
Rituximab: a new therapeutic alternative in rheumatoid arthritis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rituximab: a new therapeutic alternative in rheumatoid arthritis.
@en
Rituximab: a new therapeutic alternative in rheumatoid arthritis.
@nl
type
label
Rituximab: a new therapeutic alternative in rheumatoid arthritis.
@en
Rituximab: a new therapeutic alternative in rheumatoid arthritis.
@nl
prefLabel
Rituximab: a new therapeutic alternative in rheumatoid arthritis.
@en
Rituximab: a new therapeutic alternative in rheumatoid arthritis.
@nl
P1433
P1476
Rituximab: a new therapeutic alternative in rheumatoid arthritis.
@en
P2093
Jean Sibilia
Xavier Mariette
P304
P356
10.1016/J.JBSPIN.2008.02.009
P577
2008-06-20T00:00:00Z